Pyr-T
|
| Names
|
Preferred IUPAC name
3-[2-(Pyrrolidin-1-yl)ethyl]-1H-indole
|
| Other names
N,N-Tetramethylenetryptamine
|
| Identifiers
|
|
|
|
|
|
|
|
ChemSpider
|
|
|
|
|
|
UNII
|
|
|
|
|
InChI=1S/C14H18N2/c1-2-6-14-13(5-1)12(11-15-14)7-10-16-8-3-4-9-16/h1-2,5-6,11,15H,3-4,7-10H2 Y
Key: CVTZCBLFHNGYDQ-UHFFFAOYSA-N Y
InChI=1/C14H18N2/c1-2-6-14-13(5-1)12(11-15-14)7-10-16-8-3-4-9-16/h1-2,5-6,11,15H,3-4,7-10H2
Key: CVTZCBLFHNGYDQ-UHFFFAOYAE
|
c2c(c1ccccc1[nH]2)CCN3CCCC3
|
| Properties
|
|
|
C14H18N2
|
|
Molar mass
|
214.312 g·mol−1
|
|
Melting point
|
193 to 194 °C (379 to 381 °F; 466 to 467 K) (HCl salt.)
|
|
Boiling point
|
170 to 180 °C (338 to 356 °F; 443 to 453 K) (Freebase at 0.05mm/Hg.)
|
|
log P
|
2.74410
|
|
Vapor pressure
|
1.02x10−5mmHg
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Pyr-T (N,N-tetramethylenetryptamine) is a lesser-known, possible psychedelic drug. Pyr-T was first characterized by S. Mitzal. Toxicity testing was later performed by Hunt and Brimblecombe, and although a lethal dosage was found in rats, a value is not given. In the book TiHKAL (Tryptamines I Have Known and Loved), neither the dosage nor the duration are reported.
Pyr-T produces few to no effects in humans, but some behavioral changes were observed in animal tests. Very little data exists about the pharmacological properties, metabolism, and toxicity of pyr-T.
See also
|
|
- 1-Methylpsilocin
- 2,alpha-DMT
- 2-Me-DET
- 2-Methyl-5-HT
- 2,N,N-TMT
- 4,5-DHP-DMT
- 4,5-MDO-DMT
- 4,5-MDO-DiPT
- 4-AcO-DALT
- 4-AcO-DET
- 4-AcO-DMT
- 4-AcO-DiPT
- 4-AcO-EPT
- 4-AcO-NMT
- 4-AcO-MALT
- 4-AcO-MET
- 4-AcO-DPT
- 4-AcO-MiPT
- 4-F-5-MeO-DMT
- 4-HO-5-MeO-DMT
- 4-HO-DALT
- 4-HO-DBT
- 4-HO-DET
- 4-HO-DiPT
- 4-HO-DPT
- 4-HO-DSBT
- 4-HO-EPT
- 4-HO-MALT
- 4-HO-MET
- 4-HO-McPT
- 4-HO-McPeT
- 4-HO-MiPT
- 4-HO-MPMI
- 4-HO-MPT
- 4-HO-MsBT
- 4-HO-NMT
- 4-HO-PiPT
- 4-HO-pyr-T
- 4-HO-αMT
- 4-Me-αET
- 4-Me-αMT
- 4-MeO-DiPT
- 4-MeO-DMT
- 4-MeO-MiPT
- 4-PrO-DMT
- 5,6-MeO-MiPT
- 5,6-MDO-DiPT
- 5,6-MDO-DMT
- 5,6-MDO-MiPT
- 5,7-Dihydroxytryptamine
- 5-BT
- 5-Bromo-DMT
- 5-CT
- 5-Chloro-αMT
- 5-Chloro-DMT
- 5-Ethoxy-αMT
- 5-Ethoxy-DMT
- 5-Ethyl-DMT
- 5-Fluoro-AET
- 5-Fluoro-αMT
- 5-Fluoro-DET
- 5-Fluoro-DMT
- 5-Fluoro-EPT
- 5-Fluoro-MET
- 5-HO-αMT
- 5-HO-DiPT
- 5-HTP
- 5-iPrO-AMT
- 5-MeS-DMT
- 5-Methoxytryptamine
- 5-MeO-7,N,N-TMT
- 5-Methyl-αET
- 5-MeO-2-TMT
- 5-MeO-αET
- 5-MeO-αMT
- 5-MeO-DALT
- 5-MeO-DBT
- 5-MeO-DET
- 5-MeO-DiPT
- 5-MeO-DMT
- 5-MeO-DPT
- 5-MeO-EiPT
- 5-MeO-EPT
- 5-MeO-MALT
- 5-MeO-MET
- 5-MeO-MiPT
- 5-MeO-MPMI
- 5-MeO-NMT
- 5-MeO-pyr-T
- 5-MeO-NBpBrT
- 5-Methyl-DMT
- 5-(Nonyloxy)tryptamine
- 6-Fluoro-αMT
- 6-Fluoro-DMT
- 6-Hydroxymelatonin
- 6-MeO-THH
- 7-Chloro-AMT
- 7-Methyl-α-ethyltryptamine
- 7-Methyl-DMT
- Acetryptine
- Aeruginascin
- αET
- Alpha,N-DMT
- α,N,N-Trimethyltryptamine
- Alpha,N,O-TMS
- AL-37350A
- αMT
- Baeocystin
- BNC-210
- Bufotenidine
- Bufotenin (5-HO-DMT)
- BW-723C86
- Convolutindole A
- CP-132,484
- DALT
- DBT
- Desformylflustrabromine
- DET
- DiPT
- DPT
- E-6801
- E-6837
- Ethocybin
- EiPT
- EMDT
- EPT
- FGIN-127
- FGIN-143
- Harmaline
- HIOC
- Ibogaine
- Idalopirdine
- Indorenate
- Iprocin
- Lespedamine
- Luzindole
- MET
- Methylbutyltryptamine
- MiPT
- MPT
- Miprocin
- Melatonin
- MPMI
- MS-245
- NAS
- N-Ethyltryptamine
- N-Feruloylserotonin
- NMT
- DMT
- Norbaeocystin
- Normelatonin
- N-t-Butyltryptamine
- O-4310
- Oxypertine
- Plakohypaphorine
- PiPT
- Psilocin (4-HO-DMT)
- Psilocybin (4-PO-DMT)
- Pyr-T
- Rizatriptan
- RU-28306
- Serotonin
- ST-1936
- Sumatriptan
- Tryptamine
- Tryptophan
- Yohimbine
- Yuremamine
- Zolmitriptan
|